<DOC>
	<DOCNO>NCT00898417</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood laboratory patient undergoing treatment non-small cell lung cancer may help doctor predict patient respond treatment . PURPOSE : This laboratory study look proteomic pattern store blood sample patient undergoing treatment non-small cell lung cancer .</brief_summary>
	<brief_title>Biomarker Study Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin Paclitaxel With Without Bevacizumab</brief_title>
	<detailed_description>OBJECTIVES : Primary - To develop serum proteomic classifier use matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry analysis blood sample patient non-squamous cell non-small cell lung cancer predict benefit , term survival time progression , treatment bevacizumab combination carboplatin paclitaxel . Secondary - To better quantitate candidate biomarkers use advanced mass spectrometric technology , include multiple-reaction monitoring heavy-labeled peptide . OUTLINE : Previously collect pre-treatment sample serum plasma randomly select patient enrol protocol ECOG-4599 ( i.e. , 60 bevacizumab arm 30 control arm ) . Samples analyze matrix-assisted laser-desorption/ionization time-of-flight mass spectrometry identify pattern protein spectra correlate patient survival .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Available serum plasma sample patient previously untreated locally advanced , metastatic , recurrent nonsquamous cell nonsmall cell lung cancer Enrolled clinical trial ECOG4599 Treated carboplatin paclitaxel without bevacizumab PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>